Common aspects of the action of nicotine and other drugs of abuse

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 165-172

  Picciotto, Marina R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; NICOTINE; NICOTINIC RECEPTOR; PSYCHOSTIMULANT AGENT;

ANXIETY; COGNITION; DRUG ABUSE; HUMAN; LIMBIC SYSTEM; LOCOMOTION; LOCUS CERULEUS; MENTAL STRESS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SMOKING;

EID: 0032104720     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00074-X     Document Type: Article

References (117)

1. Anand, R., Conroy, W.G., Schoepfer, R., Whiting, P., Lindstrom, J., 1991. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266, 11192-11198.
2. Beitner-Johnson, D., Nestler, E.J., 1991. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57, 344-347.
3. Benwell, M.E., Balfour, D.J., Khadra, L.F., 1994. Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine. Clin. Invest. 72, 233-239.
4. Breslau, N., Kilbey, M.M., Andreski, P., 1993. Nicotine dependence and major depression: new evidence from a prospective investigation. Arch. Gen. Psychiatry 50, 31-35.
5. Brioni, J.D., O'Neill, A.B., Kim, D.J.B., Decker, M.W., 1993. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238, 1-8.
6. Burling, T.A., Ziff, D.C., 1988. Tobacco smoking: a comparison between alcohol and drug abuse inpatients. Addict. Behav. 13, 185-190.
7. Butschky, M.F., Bailey, D., Henningfield, J.E., Pickworth, W.B., 1995. Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol. Biochem. Behav. 50, 91-96.
8. Calabresi, P., Lacey, M.G., North, R.A., 1989. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol. 98, 135-140.
9. Cao, W., Burkholder, T., Wilkins, L., Collins, A.C., 1993. A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacol. Biochem. Behav. 45, 803-809.
10. Carr, L.A., Rowell, P.P., Pierce, W.M., Jr., 1989. Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem. Res. 14, 511-515.
11. Clarke, P.B., Fibiger, H.C., 1987. Apparent absence of nicotine-induced conditioned place preference in rats. Psychopharmacology 92, 84-88.
12. Clarke, P.B.S., Kumar, R., 1983. Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 80, 587-594.
13. Clarke, P.B.S., Pert, A., 1985. Autoradiographic evidence for nicotine receptors in nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348, 355-358.
14. Clarke, P.B., Fu, D.S., Jakubovic, A., Fibiger, H.C., 1988. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246, 701-708.
15. Cooper, E., Couturier, S., Ballivet, M., 1991. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350, 235-238.
16. Corrigall, W.A., Coen, K.M., 1989. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99, 473-478.
17. Corrigall, W.A., Franklin, K.B., Coen, K.M., Clarke, P.B., 1992. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl.) 107, 285-289.
18. Costall, B., Kelly, M.E., Naylor, R.J., Onaivi, E.S., 1989. The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol. Biochem. Behav. 33, 197-203.
19. Cox, B.M., Goldstein, A., Nelson, W.T., 1984. Nicotine self-administration in rats. Br. J. Pharmacol. 83, 49-55.
20. Davis, M., 1992. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. TiPS 13, 35-41.
21. Deneris, E.S., Boulter, J., Swanson, L.W., Patrick, J., Heinemann, S., 1989. β3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain. J. Biol. Chem. 264, 6268-6272.
22. Eissenberg, T., Griffiths, R.R., Stitzer, M.L., 1996. Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology 127, 328-336.
23. Flicker, C., Dean, R.L., Watkins, D.L., Fisher, S.K., Bartus, R.T., 1983. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in rat. Pharmacol. Biochem. Behav. 18, 973-981.
24. Flores, C.M., Rogers, S.W., Pabreza, L.A., Wolfe, B.B., Kellar, K.J., 1992. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha4-subunit and beta2-subunit and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37.
25. Freedman, R., Hall, M., Adler, L.E., Leonard, S., 1995. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38, 22-33.
26. Galzi, J.-L., Revah, F., Bessis, A., Changeux, J.-P., 1991. Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu. Rev. Pharmacol. 31, 37-72.
27. Gilbert, D.G., Robinson, J.H., Chamberlin, C.L., Spielberger, C.D., 1989. Effects of smoking nicotine on anxiety, heart rate and lateralization of EEG suring a stressful movie. Psychophysiology 26, 311-319.
28. Glassman, A.H., Covey, L.S., Dalack, G.W., et al., 1993. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin. Pharmacol. Ther. 54, 670-679.
29. Glick, S.D., Visker, K.E., Maisonneuve, I.M., 1996. An oral self-administration model of nicotine preference in rats - effects of mecamylamine. Psychopharmacology 128, 426-431.
30. Goldberg, S.R., Spealman, R.D., Goldberg, D.M., 1981. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214, 573-575.
31. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59, 848-856.
32. Gray, R., Rajan, A.S., Radcliffe, K.A., Yakehiro, M., Dani, J.A., 1996. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716.
33. Grunberg, N.E., Popp, K.A., Bowen, D.J., Nespor, S.M., Winders, S.E., Eury, S.E., 1988. Effects of chronic nicotine administration on insulin, glucose, epinephrine, and norepinephrine. Life Sci. 42, 161-170.
34. Guitart, X., Hayward, M., Nisenbaum, L.K., Beitner-Johnson, D.B., Haycock, J.W., Nestler, E.J., 1990. Identification of MARPP-58, a morphine-and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus. J. Neurosci. 10, 2649-2659.
35. Hall, S.M., Munoz, R.F., Reus, V.I., Sees, K.L., 1993. Nicotine, negative affect and depression. J. Consult. Clin. Psychol. 61, 761-767.
36. Henningfield, J.E., Miyasato, K., Jasinski, D.R., 1983. Cigarette smokers self-administer intravenous nicotine. Pharmacol. Biochem. Behav. 19, 887-890.
37. Hildebrand, B.E., Nomikos, G.G., Bondjers, C., Nisell, M., Svensson, T.H., 1997. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology 129, 348-356.
38. 2 subunit. J. Neurosci. 13, 1551-1568.
39. Hoskins, B., Oh, S.K., Tseng, Y.T., Rockhold, R.W., Ho, I.K., 1990. Effects of cocaine on tyrosine hydroxylase activity in brain areas from SHR and WKY. Brain Res. Bull. 25, 639-641.
40. Hughes, J.R., Hatsukami, D.K., Mitchell, J.E., Dahlgren, L.A., 1986. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143, 993-997.
41. Hughes, J.R., Higgins, S.T., Bickel, W.K., 1994. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89, 1461-1470.
42. Imperato, A., Mulas, A., Di Chiara, G., 1986. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132, 337-338.
43. Johnson, D.H., Svensson, A.I., Engel, J.A., Soderpalm, B., 1995. Induction but not expression of behavioural sensitization to nicotine in the rat is dependent on glucocorticoids. Eur. J. Pharmacol. 276, 155-164.
44. Jorenby, D.E., Steinpreis, R.E., Sherman, J.E., Baker, T.B., 1990. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology 101, 533-538.
45. Kalivas, P.W., Sorg, B.A., Hooks, M.S., 1993. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4, 315-334.
46. Kassel, J.D., 1997. Smoking and attention - a review and reformulation of the stimulus-filter hypothesis. Clin. Psychol. Rev. 17, 451-478.
47. Le Novère, N., Changeux, J.-P., 1995. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40, 155-172.
48. Le Novère, N., Zoli, M., Changeux, J.-P., 1996. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8, 2428-2439.
49. Leikola-Pelho, T., Jackson, D.M., 1992. Preferential stimulation of locomotor activity by ventral tegmental microinjections of (-)-nicotine. Pharmacol. Toxicol. 70, 50-52.
50. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J. Neurosci. 17, 576-585.
51. Léna, C., Changeux, J.P., Mulle, C., 1993. Evidence for 'preterminal' nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13, 2680-2688.
52. Levin, E.D., 1992. Nicotinic systems and cognitive function. Psychopharmacology (Berl.) 108, 417-431.
53. Levin, E.D., Christopher, N.C., Briggs, S.J., Rose, J.E., 1993. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basocortical projection. Cognit. Brain Res. 1, 137-143.
54. Lichtensteiger, W., Hefti, F., Felix, D., Huwyler, T., Melamed, E., Schlumpf, M., 1982. Stimulation of nigrostriatal dopamine neurones by nicotine. Neuropharmacology 21, 963-968.
55. Listerud, M., Brussaard, A.B., Devay, P., Colman, D.R., Role, L.W., 1991. Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. Science 254, 1518-1521.
56. Malin, D.H., Lake, J.R., Newlin-Maultsby, P., et al., 1992. Rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 43, 779-784.
57. Malin, D.H., Lake, J.R., Carter, V.A., Cunningham, J.S., Wilson, O.B., 1993. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112, 339-342.
58. Malin, D.H., Lake, J.R., Carter, V.A., et al., 1994. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 115, 180-184.
59. Marks, M., Campbell, S., Romm, E., Collins, A., 1991. Genotype influences the development of tolerance to nicotine in the mouse. J. Pharmacol. Exp. Ther. 259, 392-402.
60. Marshall, D.L., Redfern, P.H., Wonnacott, S., 1997. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J. Neurochem. 68, 1511-1519.
61. McGehee, D.S., Heath, M.J., Gelber, S., Devay, P., Role, L.W., 1995. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
62. Merlo Pich, E., Pagliusi, S.R., Tessari, M., Talabot-Ayer, D., Hooft van Huijsduijnen, R., Chiamulera, C., 1997. Common neural substrates for the addictive properties of nicotine and cocaine. Science 275, 83-86.
63. Mifsud, J.-C., Hernandez, L., Hoebel, B.G., 1989. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res. 478, 365-367.
64. Mitchell, S.N., Smith, K.M., Joseph, M.H., Gray, J.A., 1993. Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 56, 989-997.
65. Muir, J.L., Dunnett, S.B., Robbins, T.W., Everitt, B.J., 1992. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholonium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple choice, serial reaction time task. Exp. Brain Res. 89, 611-622.
66. Mulle, C., Choquet, D., Korn, H., Changeux, J.P., 1992. Calcium influx through nicotinic receptor in rat central neurons - its relevance to cellular regulation. Neuron 8, 135-143.
67. Museo, E., Wise, R.A., 1990. Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion. Pharmacol. Biochem. Behav. 37, 113-116.
68. Museo, E., Wise, R.A., 1994. Place preference conditioning with ventral tegmental injections of cytisine. Life Sci. 55, 1179-1186.
69. Museo, E., Wise, R.A., 1995. Cytisine-induced behavioral activation: delineation of neuroanatomical locus of action. Brain Res. 670, 257-263.
70. Nairn, A.C., Picciotto, M.R., 1994. Calcium/calmodulin-dependent protein kinases. Semin. Cancer Biol. 5, 295-303.
71. Nestler, E., 1992. Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
72. Nordberg, A., Nilson-Hakansson, L., Adem, A., et al., 1989. The role of nicotinic receptors in pathophysiology of Alzheimer's disease. Prog. Brain Res. 79, 353-362.
73. Nye, H.E., Nestler, E.J., 1996. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645.
74. Nye, H.E., Hope, B.T., Kelz, M.B., Iadarola, M., Nestler, E.J., 1995. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275, 1671-1680.
75. Ortiz, J., Fitzgerald, L.W., Charlton, M., et al., 1995. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21, 289-298.
76. Panagis, G., Nisell, M., Nomikos, G.G., Chergui, K., Svensson, T.H., 1996. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res. 730, 133-142.
77. Picciotto, M.R., Zoli, M., Léna, C., et al., 1995. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374, 65-67.
78. Picciotto, M.R., Zoli, M., Rimondini, R., et al., 1998. Acetylcholine receptors containing the beta-2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177.
79. Pidoplichko, V.I., Debiasi, M., Williams, J.T., Dani, J.A., 1997. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390, 401-404.
80. Pomerleau, O.F., 1986. Nicotine as a psychoactive drug: anxiety and pain reduction. Psychopharmacol. Bull. 22, 865-869.
81. Pontieri, F.E., Tanda, G., Orzi, F., Di Chiara, G., 1996. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255-257.
82. Ramirez-Latorre, J., Yu, C.R., Qu, X., Perin, F., Karlin, A., Role, L., 1996. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels. Nature 380, 347-351.
83. Rasmussen, K., Czachura, J.F., 1995. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons. Neuroreport 7, 329-332.
84. Rathouz, M.M., Berg, D.K., 1994. Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J. Neurosci. 14, 6935-6945.
85. Risinger, F.O., Oakes, R.A., 1995. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol. Biochem. Behav. 51, 457-461.
86. Risner, M.E., Goldberg, S.R., 1983. A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J. Pharmacol. Exp. Ther. 224, 319-326.
87. Robinson, J.H., Pritchard, W.S., 1992. The role of nicotine in tobacco use. Psychopharmacology 108, 397-407.
88. Robinson, S.F., Marks, M.J., Collins, A.C., 1996. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology 124, 332-339.
89. Robinson, T.E., Berridge, K.C., 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
90. Rogers, M., Dani, J.A., 1995. Comparison of quantitative calcium flux through NMDA, ATP, and ACh receptor channels. Biophys. J. 68, 501-506.
91. Role, L.W., 1992. Diversity in primary structure and function of neuronal acetylcholine receptor channels. Curr. Opin. Neurobiol. 2, 254-262.
92. Romano, C., Goldstein, A., 1980. Sterospecific nicotine receptors on rat brain membranes. Science 210, 647-650.
93. 3H]dopamine from rat striatal synaptosomes. Neurosci. Lett. 189, 171-175.
94. Sargent, P.B., 1993. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16, 403-443.
95. Shiffman, S., Paty, J.A., Gnys, M., Kassel, J.D., Elash, C., 1995. Nicotine withdrawal in chippers and regular smokers: subjective and cognitive effects. Health Psychol. 14, 301-309.
96. Shoaib, M., Stolerman, I.P., Kumar, R.C., 1994. Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl.) 113, 445-452.
97. Slifer, B.L., Balster, R.L., 1985. Intravenous self-administration of nicotine: with and without schedule-induction. Pharmacol. Biochem. Behav. 22, 61-69.
98. Smith, A., Roberts, D.C., 1995. Oral self-administration of sweetened nicotine solutions by rats. Psychopharmacology 120, 341-346.
99. Smith, K.M., Mitchell, S.N., Joseph, M.H., 1991. Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J. Neurochem. 57, 1750-1756.
100. Stolerman, I.P., Jarvis, M.J., 1995. The scientific case that nicotine is addictive. Psychopharmacology 117, 2-10.
101. Summers, K.L., Giacobini, E., 1995. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem. Res. 20, 753-759.
102. Sutherland, G., Stapleton, J.A., Russell, M.A., Feyerabend, C., 1995. Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120, 418-425.
103. Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., Misawa, M., 1996. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur. J. Pharmacol. 314, 281-284.
104. Vernino, S., Amador, M., Luetje, C.W., Patrick, J., Dani, J.A., 1992. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron 8, 127-134.
105. Vidal, C., Changeux, J.P., 1993. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience 56, 23-32.
106. Vrana, S.L., Vrana, K.E., Koves, T.R., Smith, J.E., Dworkin, S.I., 1993. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J. Neurochem. 61, 2262-2268.
107. Wada, E., McKinnon, D., Heinemann, S., Patrick, J., Swanson, L.W., 1990. The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res. 526, 45-53.
108. Wada, E., Wada, K., Boulter, J., et al., 1989. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic subunit mRNAs in the central nervous system: a hybridization histochemical study in rat. J. Comp. Neurol. 284, 314-335.
109. Warburton, D.M., 1992a. Nicotine as a cognitive enhancer. Prog. Neuropsychopharmacol. Biol. Psychiatry 16, 181-199.
110. Warburton, D.M., 1992b. Nicotine issues. Psychopharmacology 108, 393-396.
111. Wesnes, K., Warburton, D.M., 1984. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology 82, 147-150.
112. Wesnes, K., Warburton, D.M., Matz, B., 1983. Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology 9, 41-44.
113. West, R., 1992. Nicotine addiction: a re-analysis of the arguments. Psychopharmacology 108, 408-410.
114. Winders, S.E., Grunberg, N.E., 1990. Effects of nicotine on body weight, food consumption and body composition in male rats. Life Sci. 46, 1523-1530.
115. Wonnacott, S., Drasdo, A., Sanderson, E., Rowell, P., 1990. Presynaptic nicotinic receptors and the modulation of transmission release. In: Block, G., Marsh, J. (Eds.), The Biology of Nicotine Dependence. Wiley, Chichester, pp. 87-105.
116. Yang, X., Criswell, H.E., Breese, G.R., 1996. Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J. Pharmacol. Exp. Ther. 276, 482-489.
117. Zoli, M., Le Novère, N., Hill, J.A.J., Changeux, J.-P., 1995. Developmental regulation of nicotinic receptor subunit mRNAs in the rat central and peripheral nervous systems. J. Neurosci. 15, 1912-1939.